stock
BIO-B · BIO-RAD LABORATORIES, INC.
What BIO-RAD LABORATORIES, INC. reports to the SEC, read from its filings.
Open in the appPrice
The live BIO-B price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on BIO-B.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- Not reported.
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 51.9%
- Operating
- 2.1%
- Net
- 8.6%
Returns
- ROE
- 3.1%
- ROA
- 2.2%
Health
- Current ratio
- 3.1x
- Debt/equity
- 0.2x
Deep value
- NCAV
- -$57.60M
- NCAV per share
- —
- Price/NCAV
- Locked
- NNWC
- -$1.84B
- NNWC per share
- —
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $651.00M | $345.80M | $72.60M | $371.40M | 10-Q filed 2026-08-04 |
| 2026-03-31 | $592.10M | $309.40M | $34.10M | -$527.10M | 10-Q filed 2026-08-04 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $693.20M | $345.20M | -$118.90M | $720.00M | 10-K filed 2026-02-13 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $653.00M | $343.40M | $65.30M | -$341.90M | 10-Q filed 2025-10-29 |
| 2025-06-30 | $651.60M | $345.30M | $77.10M | $317.80M | 10-Q filed 2026-08-04 |
| 2025-03-31 | $585.40M | $306.00M | $23.70M | $64.00M | 10-Q filed 2026-08-04 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $667.50M | $342.00M | $58.40M | -$715.80M | 10-K filed 2026-02-13 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $649.70M | $355.90M | $64.50M | $653.20M | 10-Q filed 2025-10-29 |
- Assets
- $10.25B
- Equity
- $7.17B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $2.58B | $47.20M | $759.90M | $374.60M |
| 2024-12-31 | $2.57B | $269.00M | -$1.84B | $289.60M |
| 2023-12-31 | $2.67B | $337.80M | -$637.30M | $218.20M |
| 2022-12-31 | $2.80B | $482.60M | -$3.63B | $81.60M |
| 2021-12-31 | $2.92B | $500.34M | $4.25B | $535.72M |
| 2020-12-31 | $2.55B | $421.33M | $3.81B | $476.41M |
| 2019-12-31 | $2.31B | $229.66M | $1.76B | $359.37M |
| 2018-12-31 | $2.29B | -$103.34M | $365.61M | $155.67M |
| 2017-12-31 | $2.16B | $119.25M | $122.25M | -$7.20M |
| 2016-12-31 | $2.07B | $55.72M | $26.00M | $74.63M |
Company filings
events
Results, Exit or restructuring costs, Regulation FD disclosure
ResultsExit or restructuring costsRegulation FD disclosureAug 48-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureApr 308-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsApr 248-KRegulation FD disclosure
Regulation FD disclosureFeb 198-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureFeb 128-KResults, Regulation FD disclosure
ResultsRegulation FD disclosure10/29/20258-K
5% owners ()
The Vanguard Group
Stake update
Norman D. Schwartz
Stake update
Norman D. Schwartz
Stake update
Norman D. Schwartz
Stake update
Norman D. Schwartz
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
Couldn’t load politician trades
This read is unavailable. Try it again without changing anything on the page.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named BIO-B, and the market events around them.
Sign in to see thisBoard
The BIO-B board could not be loaded.
Retry the BIO-B boardnakagai
Signals on BIO-B come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the BIO-B board